scispace - formally typeset
K

Keisuke Hino

Researcher at Kawasaki Medical School

Publications -  148
Citations -  12248

Keisuke Hino is an academic researcher from Kawasaki Medical School. The author has contributed to research in topics: Hepatitis C virus & Hepatocellular carcinoma. The author has an hindex of 36, co-authored 139 publications receiving 10901 citations. Previous affiliations of Keisuke Hino include Yamaguchi University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Yasuhito Tanaka, +28 more
- 01 Oct 2009 - 
TL;DR: A genome-wide association study to null virological response (NVR) in the treatment of patients with hepatitis C virus (HCV) genotype 1 within a Japanese population is reported.
Journal ArticleDOI

Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria.

Hiroki Nishikawa, +5 more
- 01 Sep 2016 - 
TL;DR: The assessment criteria for sarcopenia in liver disease proposed by the Japan Society of Hepatology (JSH) are summarized in this article, where the authors present the assessment criteria to the best of their knowledge.
Journal ArticleDOI

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

Masatoshi Kudo, +26 more
- 01 Aug 2020 - 
TL;DR: TACE plus sorafenib significantly improved PFS over TACE alone in patients with unresectable HCC, and Adverse events were consistent with those of previous TACE combination trials.
Journal ArticleDOI

Hepatitis C Virus–Induced Reactive Oxygen Species Raise Hepatic Iron Level in Mice by Reducing Hepcidin Transcription

Sohji Nishina, +11 more
- 01 Jan 2008 - 
TL;DR: HCV-induced reactive oxygen species may down-regulate hepcidin transcription through inhibition of C/EBPalpha DNA binding activity by C/EBP homology protein, which in turn leads to increased duodenal iron transport and macrophage iron release, causing hepatic iron accumulation.